| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |